AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Igene Biotechnology, Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
15.65K
AVG Volume
65.32K
Trailing/Forward PE
-0.1/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M2M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Revenue (USD) by quarter
PeriodRevenue (USD)
10 Q30
10 Q20
10 Q10
09 Q44.8K
09 Q31.12M
09 Q21.6M
09 Q11.24M
08 Q41.38M
08 Q31.73M
08 Q21.66M
Net Income (USD)
-2M-1M01M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Net Income (USD) by quarter
PeriodNet Income (USD)
10 Q3-627.24K
10 Q2-811.21K
10 Q1-549.05K
09 Q4-386.39K
09 Q3114.81K
09 Q2-601.91K
09 Q1732.74K
08 Q4-1.37M
08 Q3-798.47K
08 Q2-955.64K
Operating Income (USD)
-1.5M-1M-500K0500K08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Operating Income (USD) by quarter
PeriodOperating Income (USD)
10 Q3-625.5K
10 Q2-822.07K
10 Q1-540.88K
09 Q4-343.17K
09 Q3151.21K
09 Q2-593.78K
09 Q1-284.13K
08 Q4-1.22M
08 Q3-245.44K
08 Q2-404.75K
EBITDA (USD)
-1.5M-1M-500K0500K1M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE EBITDA (USD) by quarter
PeriodEBITDA (USD)
10 Q3-57.76K
10 Q2-88.95K
10 Q1-109.92K
09 Q4-201.15K
09 Q3612.68K
09 Q2-228.28K
09 Q1-43.79K
08 Q4-1.12M
08 Q3-240.28K
08 Q2-399.32K
Cash Flows (USD)
-2M-1M01M2M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Cash Flows (USD) by quarter
PeriodCash Flows (USD)
10 Q3-710.59K
10 Q2-297.23K
10 Q1-12.67K
09 Q4-644.88K
09 Q3-689.75K
09 Q21.17M
09 Q1-109.04K
08 Q4384.81K
08 Q3-91.77K
08 Q2-1.61M
EPS (USD)
-0.01-0.01-0-00008 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE EPS (USD) by quarter
PeriodEPS (USD)
10 Q3-0
10 Q2-0
10 Q1-0
09 Q4-0
09 Q30
09 Q2-0
09 Q10
08 Q4-0
08 Q3-0.01
08 Q2-0.01
Expenses (USD)
-500K0500K1M1.5MR&DSG&ACapex08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Expenses (USD) by quarter
PeriodExpenses (USD)
10 Q3669.17K
10 Q2816.17K
10 Q1678.57K
09 Q4803.77K
09 Q3702.18K
09 Q2763.25K
09 Q1979.67K
08 Q41.01M
08 Q3779.22K
08 Q2892.92K
Cash & Debt (USD)
010M20M30MCashLong Term DebtShort Term Debt08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
10 Q3269.29K
10 Q2977.38K
10 Q11.28M
09 Q41.3M
09 Q32.62M
09 Q21.53M
09 Q1937.56K
08 Q41.49M
08 Q31.15M
08 Q21.26M
Debt ratios
-5005010008 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Debt ratios by quarter
PeriodDebt ratios
10 Q3-15.44
10 Q229.87
10 Q180.75
09 Q439.45
09 Q3-6.07
09 Q2-2.88
09 Q1-2.75
08 Q4-1.86
08 Q3-22.26
08 Q2-32.38
Margins
-250%0%250%500%750%1000%03 Q207 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q309 Q4
IGNE Margins by quarter
PeriodMargins
09 Q4850.27%
09 Q358.64%
09 Q21.49%
09 Q123.88%
08 Q4-13.22%
08 Q328.94%
08 Q225.73%
08 Q117.55%
07 Q426.46%
03 Q25.73%
Return on Capital
-50%-25%0%25%50%75%08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Return on Capital by quarter
PeriodReturn on Capital
10 Q313.39%
10 Q219.98%
10 Q116.9%
09 Q414.09%
09 Q3-4.83%
09 Q224.26%
09 Q1-37.9%
08 Q451.03%
08 Q34.71%
08 Q25.92%
Shares Outstanding
0500M1B1.5B2B08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Shares Outstanding by quarter
PeriodShares Outstanding
10 Q31.57B
10 Q21.57B
10 Q11.56B
09 Q41.55B
09 Q31.55B
09 Q21.52B
09 Q11.52B
08 Q4852.77M
08 Q3110.34M
08 Q2110.34M
Book Value Per Share (USD)
-0.2-0.15-0.1-0.05-008 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
10 Q3-0
10 Q2-0
10 Q1-0
09 Q4-0
09 Q3-0
09 Q2-0
09 Q1-0
08 Q4-0
08 Q3-0.15
08 Q2-0.15
Total Assets (USD)
02.5M5M7.5M10M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Total Assets (USD) by quarter
PeriodTotal Assets (USD)
10 Q33.41M
10 Q24M
10 Q14.64M
09 Q44.76M
09 Q35.67M
09 Q25.14M
09 Q15.38M
08 Q46.07M
08 Q37.58M
08 Q28.82M
Free Cash Flow Yield
-10638.75%-10638.5%-10638.25%-10638%-10637.75%-10637.5%med -10638.64%Jan 25May 25Sep 25Jan 26May 26Sep 26
IGNE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-10638.64%
Sep 26-10638.64%
Sep 26-10638.64%
Aug 26-10638.64%
Aug 26-10638.64%
Aug 26-10638.64%
Aug 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jun 26-10638.64%
Jun 26-10638.64%
Jun 26-10638.64%
Jun 26-10638.64%
May 26-10638.64%
May 26-10638.64%
May 26-10638.64%
May 26-10638.64%
May 26-10638.64%
Apr 26-10638.64%
Apr 26-10638.64%
Apr 26-10638.64%
Apr 26-10638.64%
Mar 26-10638.64%
Mar 26-10638.64%
Mar 26-10638.64%
Mar 26-10638.64%
Feb 26-10638.64%
Feb 26-10638.64%
Feb 26-10638.64%
Feb 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Dec 25-10638.64%
Dec 25-10638.64%
Dec 25-10638.64%
Dec 25-10638.64%
Nov 25-10638.64%
Nov 25-10638.64%
Nov 25-10638.64%
Nov 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Sep 25-10638.64%
Sep 25-10638.64%
Sep 25-10638.64%
Sep 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Jul 25-10638.64%
Jul 25-10638.64%
Jul 25-10638.64%
Jul 25-10638.64%
Jun 25-10638.64%
Jun 25-10638.64%
Jun 25-10638.64%
Jun 25-10638.64%
May 25-10638.64%
May 25-10638.64%
May 25-10638.64%
May 25-10638.64%
May 25-10638.64%
Apr 25-10638.64%
Apr 25-10638.64%
Apr 25-10638.64%
Apr 25-10638.64%
Mar 25-10638.64%
Mar 25-10638.64%
Mar 25-10638.64%
Mar 25-10638.64%
Feb 25-10638.64%
Feb 25-10638.64%
Feb 25-10638.64%
Feb 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Dec 24-10638.64%
Dec 24-10638.64%
Dec 24-10638.64%
Dec 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Oct 24-10638.64%
Price to Sales
33.544.5med 3.26Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IGNE Price to Sales by quarter
PeriodPrice to Sales
Sep 263.26
Sep 263.26
Sep 263.26
Aug 263.26
Aug 263.26
Aug 263.26
Aug 263.26
Jul 263.26
Jul 263.26
Jul 263.26
Jul 263.26
Jul 263.26
Jun 263.26
Jun 263.26
Jun 263.26
Jun 263.26
May 263.26
May 263.26
May 263.26
May 263.26
May 263.26
Apr 263.26
Apr 263.26
Apr 263.26
Apr 263.26
Mar 263.26
Mar 263.26
Mar 263.26
Mar 263.26
Feb 263.26
Feb 263.26
Feb 263.26
Feb 263.26
Jan 263.26
Jan 263.26
Jan 263.26
Jan 263.26
Jan 263.26
Dec 253.26
Dec 253.26
Dec 253.26
Dec 253.26
Nov 253.26
Nov 253.26
Nov 253.26
Nov 253.26
Oct 253.26
Oct 253.26
Oct 253.26
Oct 253.26
Oct 253.26
Sep 253.26
Sep 253.26
Sep 253.26
Sep 253.26
Aug 253.26
Aug 253.26
Aug 253.26
Aug 253.26
Aug 253.26
Jul 253.26
Jul 253.26
Jul 253.26
Jul 253.26
Jun 253.26
Jun 253.26
Jun 253.26
Jun 253.26
May 253.26
May 253.26
May 253.26
May 253.26
May 253.26
Apr 253.26
Apr 253.26
Apr 253.26
Apr 253.26
Mar 253.26
Mar 253.26
Mar 253.26
Mar 253.26
Feb 253.26
Feb 253.26
Feb 253.26
Feb 253.26
Jan 253.26
Jan 253.26
Jan 253.26
Jan 253.26
Jan 253.26
Dec 243.26
Dec 243.26
Dec 243.26
Dec 243.26
Nov 243.26
Nov 243.26
Nov 243.26
Nov 243.26
Nov 243.26
Oct 243.26
EV/EBITDA
0100200300med 172.85Apr 08Jun 08May 10Jul 10Sep 10Oct 10Dec 10
IGNE EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 1066.67
Dec 1074.03
Dec 1066.67
Dec 1059.31
Nov 1055.63
Nov 1059.31
Nov 1055.63
Nov 1066.67
Oct 1074.03
Oct 1066.67
Oct 1060.05
Oct 1060.05
Oct 10103.48
Sep 10293.87
Sep 10144.68
Sep 10272.56
Sep 10208.62
Aug 10229.93
Aug 10229.93
Aug 10229.93
Aug 10229.93
Jul 10229.93
Jul 10187.31
Jul 10187.31
Jul 10187.31
Jul 10187.31
Jun 10106.15
Jun 10106.15
Jun 10106.15
Jun 10106.15
May 10106.15
May 1095.03
May 1095.03
May 1095.03
Apr 10183.96
Apr 10150.61
Apr 10150.61
Apr 10150.61
Apr 10161.73
Jun 08233.72
Jun 08239.14
Jun 08251.34
Jun 08239.14
May 08245.92
May 08245.92
May 08245.92
May 08245.92
May 08251.34
Apr 08251.34
Apr 08245.92
Apr 08245.92
Apr 08245.92
Price/Operating Cashflow
0200004000060000med 1.59Apr 08Jul 08Oct 08Feb 09May 09Dec 09Mar 10
IGNE Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 1018.34
Mar 1016.67
Mar 1018.34
Mar 1016.67
Feb 1021.67
Feb 1016.67
Feb 1016.67
Feb 1016.67
Jan 109.67
Jan 109.67
Jan 109.67
Jan 1016.67
Dec 0916.67
Dec 095.83
Dec 095.83
Dec 095.83
Dec 097.78
Nov 097.78
Nov 0917.5
Nov 0926.25
Nov 093.89
Oct 093.11
Oct 098.26
Oct 098.75
Oct 099.82
Oct 099.82
Jun 0912.09
Jun 0912.09
Jun 0918.13
Jun 0912.09
May 0913.29
May 0913.29
May 0913.29
May 0916.92
May 0912.09
Apr 097.25
Apr 097.25
Apr 0912.09
Apr 0924.17
Mar 090.94
Mar 090.31
Mar 091.13
Mar 091.13
Feb 090.38
Feb 090.38
Feb 090.38
Feb 090.38
Jan 091
Jan 091.25
Jan 090.94
Jan 090.38
Jan 090.38
Dec 080.3
Dec 080.3
Dec 080.3
Dec 080.33
Nov 080.3
Nov 080.36
Nov 080.36
Nov 080.36
Oct 080.36
Oct 080.83
Oct 081.19
Oct 080.53
Oct 080.36
Sep 080.2
Sep 080.33
Sep 080.42
Sep 080.42
Aug 080.42
Aug 080.42
Aug 080.42
Aug 080.42
Aug 080.42
Jul 080.42
Jul 080.42
Jul 080.46
Jul 080.33
Jun 080.5
Jun 080.84
Jun 081.59
Jun 080.84
May 081.26
May 081.26
May 081.26
May 081.26
May 081.59
Apr 081.59
Apr 081.26
Apr 081.26
Apr 081.26
Jun 0748763.02
Jun 0748763.02
Jun 0744428.53
Jun 0759599.24
May 0732508.68
May 0732508.68
May 0721672.45
May 0721672.45
Apr 0736843.17
Igene Biotechnology, Inc.
IGNE
Stockpicker

Video analysis: IGNE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.